Introduction
The relation between phospholipase activation resulting in liberation of arachidonic acid (AA)' from complex glycerolipids and the cyclooxygenase pathway generating prostaglandins 1 . Abbreviations used in this paper: AA, arachidonic acid; PDS, plasmaderived serum; PG, prostaglandin; PDGF, platelet-derived growth factor, TX, thromboxane.
(PGs) and thromboxanes (TXs) is not entirely clear. Upon binding of hormones or other agonists to their respective cell surface receptor, AA is released from phospholipids through activation of phospholipases (1) (2) (3) (4) (5) (6) (7) (8) (9) . In most if not all such instances, activation of phospholipases is associated with production of PGs and TXs (1, 2, 5, 9, 10) . Therefore, it is generally believed that phospholipases control formation of PGs through release of AA. Since the intracellular pool of AA is low in mammalian cells (3, 6) , there is little doubt that eicosanoid biosynthesis is dependent on phospholipase activity. However, it is less clear whether liberation of AA is sufficient to induce the burst of PG, TX, and leukotriene formation observed in many agonist response systems.
We have used quiescent Swiss 3T3 cells stimulated to divide by platelet-derived growth factor (PDGF), the principal mitogen for connective tissue-derived cells (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , as model systems to study the relation between growth factor-induced changes in phospholipid metabolism and AA release (14-16). Cells maintained in plasma-derived serum (PDS) become arrested in the GO/GI phase of the cell cycle and can be stimulated to undergo cell cycle traverse after stimulation by PDGF in a partially synchronized fashion (17) . We proposed that PDGF and epidermal growth factor stimulate AA release from phosphatidylinositol, a minor acidic phospholipid in mammalian cells, by activation of the phospholipase C/diglyceride lipase pathway (14, 15) . This reaction sequence was first described by Bell et al. (18) and Majerus et al. (19) in thrombin-stimulated platelets.
The question we have addressed in the present report has been whether PDGF has direct effects on the PG synthesis pathway. It was of special interest to us whether PDGF has direct stimulatory effects on the key enzyme, the cyclooxygenase. Our results show that AA release from glycerolipids is not sufficient to induce the burst in PG synthesis in PDGFstimulated cells (15, 20, 21) . Instead, the growth factor greatly activates the PG synthetic enzyme system itself. This effect of PDGF appears to be mediated by both activation and rapid de novo synthesis of the cyclooxygenase. Plasma proteins and PDGF. Human or calf PDS lacking plateletderived growth promoting activity was prepared as described (17) . PDGF was prepared as described by Raines and Ross (22) . PDGF at 12 ng/ml maximally stimulated DNA synthesis in Swiss 3T3 cells.
Radioimmunoassay (RIA). The concentration of PGs was determined by RIA according to Granstrom and Kindahl (23) after reversedphase extraction of the culture medium by octadecyl C18 silica gel column chromatography according to Powell (24) and thin-layer chromatography. Briefly, I ml culture medium was removed from the dish and acidified to pH 3.6 . 900 Ml of the culture medium was applied to an octadecyl C18 silica gel column equilibrated with methanol. The column was washed twice with 3 ml double distilled H20, and the PGs were eluted with a total volume of 1.5 ml ethylacetate. The ethylacetate was dried down under a stream of N2, taken up in 1 ml methanol, and stored until further analysis at -260C. Before thinlayer chromatography, the methanol was dried down and the extract taken up in 150 Ml ethanol, applied to a 200 Mm silica gel-coated aluminum thin-layer chromatogram, and developed in solvent system of benzene/acetone/methanol/dioxane/H20, 120:80:6:3:2; vol/vol. The spot containing the respective PG was scraped from the plate and extracted with 2 ml in methanol, dried down under a stream of N2, and taken up in phosphate-buffered saline. Procedural losses were monitored by adding tracer [3H]PGs to each sample. Recoveries of PGE2 ranged from 34-61%, for 6-keto-PGFI from 54-68%, and for TXB2 from 48-72%. Cross-reactivity at 50% binding of PGE2 was 10 .1% with PGE1; <0.2% with PGAI, PGA2, PGBI, PGB2, PGD2, PGF16, PGF2a, 6-keto-PGF1., and TXB2; and <0.03% with AA. Crossreactivity at 50% binding of 6-keto-PGF1. was 6.8% with 6-keto-PGE1, 2.2% with PGF2a, 0.7% with PGE,, 0.5% with PGE2, <0.1% with all other PGs tested, and <0.3% with AA. Water samples subjected to exactly the same treatment as the biological samples ranged between 0 and 7 pg/ml for PGE2 and <5-15 pg/ml for 6-keto-PGF16. Intraassay variation for PGE2 was 2-9% and for 6-keto-PGF1,, was 7-11%. Interassay variation for PGE2 was 5-12% and for 6-keto-PGFI. was 8-22%.
Results
Kinetics of PGE2 synthesis in the cell cycle of Swiss 3T3 cells stimulated by PDGF. The synthesis kinetics of PGE2 in quiescent and PDGF-stimulated cells is shown in Fig. 1 (Fig. 1 B) . No of AA in Swiss 3T3 cells (25) , over a period of 12 h (Fig. 4) .
6-keto-PGFI,, levels increased up to 2 h upon stimulation by PDGF and then remained relatively constant or increased slightly for the next 10 h. In addition, PDGF-stimulated 6-keto-PGFIa formation from exogenous AA (Fig. 4) . When PDGF stimulated cells incubated with AA were compared with quiescent cells incubated with AA, it became apparent that the growth factor stimulated 6-keto-PGF1,, synthesis by a factor of 27-35 in two experiments. Thus, the degree of stimulation of 6-keto-PGF,, formation from exogenous AA was similar to that of PGE2 synthesis (Fig. 3) . Other experiments demonstrated comparable effects of PDGF on synthesis of TXB2 and PGF2a, from exogenous AA (results not shown).
PDGF stimulates PG synthesis by two distinct mechanisms. To obtain further information on the mechanism of PG synthesis stimulation by the growth factor, we examined the effect of the protein synthesis inhibitor cycloheximide on synthesis of PGE2 (Table II) . The concentration of cycloheximide used inhibited protein synthesis >90% as determined by ['4C]leucine incorporation into trichloroacetic acid-precipitable material. While cycloheximide did not inhibit the early increase of endogenous PGE2 synthesis, the second increase was completely prevented. Since this effect of cycloheximide might have been due to protein synthesis-sensitive phospholipase activation and AA release, we determined PGE2 synthesis after cycloheximide treatment from exogenous AA (Table II) RIA of 6-keto-PGFI,, the stable degradation product of PGI2 as described under Methods. Culture medium was treated as described for PGE2. However, before thin-layer chromatography, PG extracts from two cultures were pooled to obtain sufficient amounts of 6-keto-PGFa for determination by RIA. The data represent the means of three parallel pooled duplicate cultures±SD.
incubated with cycloheximide at 6 h. A rapid decline in PGE2 synthesis from exogenous AA was observed (Fig. 5) . These results showed that the growth factor stimulated the PG synthetic enzyme system by two independent mechanisms: one that was insensitive to protein synthesis inhibition and another requiring translational activity. It is noteworthy that cycloheximide did not compromise the viability of the cells as judged by trypan exclusion under our experimental conditions. PDGF stimulates activation and rapid de novo synthesis of cyclooxygenase. To determine whether PDGF had direct effects on cyclooxygenase, we preincubated quiescent cells with aspirin (26) . We then determined the kinetics of recovery by measurement of PGE2 synthesis from exogenous AA upon removal of aspirin and stimulation with PDGF (Fig. 6) . The stimulated cells largely recovered between 2 and 4 h. Furthermore, aspirin treatment resulted in up to 45% enhanced PGE2 synthesis from exogenous AA when compared with PDGF-stimulated Fig. 1 . The data represent the means of three parallel cultures± I SD.
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Habenicht et al .0, 100 AM aspirin (ASA pr.) dissolved in 50 Ml phosphate-buffered saline. Before replacement of the medium containing PDS protein, the monolayers were washed twice with 2 ml phosphate-buffered saline to remove residual aspirin. At the time of the medium change, the cultures were divided into two groups and received either 50 Ml 10 mM acetic acid or 12 ng/ml PDGF in a concentrated solution of 50 Al 10 mM acetic acid. 60 min before each time point indicated in the figure, the cultures were incubated with 10 AM AA dissolved in a concentrated solution of 10 Ml ethanol. PGE2 levels were determined as described under Methods. The data represent the means of three parallel cultures±SD. cells in three experiments. No significant recovery from aspirin treatment was observed within the first 2 h after PDGF stimulation.
We next examined the kinetics of recovery from cyclooxygenase inhibition in PDGF-treated cells (Fig. 7) . Complete recovery was observed within 180 min in PDGF-stimulated cells when cyclooxygenase inhibition was initiated between 5.5 and 7 h. The kinetics of recovery from cyclooxygenase inhibition (Fig. 7) was similar to the kinetics of inhibition of PGE2 synthesis from exogenous AA after protein synthesis inhibition (Fig. 5) . In addition, recovery from cyclooxygenase inhibition by aspirin was completely prevented by cycloheximide (results not shown).
Discussion
The experiments performed in this investigation focused on the possibility that human PDGF stimulated synthesis of PGs by direct activation of the cyclooxygenase pathway.
The generally accepted view of PG synthesis regulation has been that AA hydrolysis from complex glycerolipids represents the major control mechanism of PG biosynthesis (1-3, 6, 9, 18 Figure 7 . Kinetics of recovery from cyclooxygenase inhibition by aspirin 7 h after stimulation of quiescent Swiss 3T3 cells with PDGF. Swiss 3T3 cells were cultured as described in Fig. 1 . On day 4, the cultures were fed with medium containing 1.25 mg/ml PDS protein, divided into two groups, and received either 50 Ml 10 mM acetic acid or 12 ng/ml PDGF in a concentrated solution of 50 Ml 10 mM acetic acid. Before the time points indicated, the cultures received 10 mM AA dissolved in a concentrated solution of ethanol. Between 5.5 and 7 h, parallel cultures were incubated with 50 Ml phosphate-buffered saline or 100 MM aspirin (ASA h 5.5-7) dissolved in 50 Ml phosphatebuffered saline. Before addition of aspirin, the medium of the cultures was replaced by fresh medium containing 1.24 mg/ml PDS protein to remove PGs that had accumulated during the 5.5 h after PDGF stimulation. PGE2 levels were determined as described under Methods. The data represent the means of three parallel cultures±SD.
PG synthesis from endogenous but not exogenous AA (27) . Furthermore most if not all agonists eliciting increased PG synthesis concomitantly induce release of AA from phospholipids (3, 9, 14, 15, 20, 21, (28) (29) (30) . While these studies are consistent with a critical role of phospholipase activity for PG synthesis, they do not provide information on several important questions: First, is AA release induced by phospholipases sufficient to induce the burst of PG synthesis observed in many agonist response systems? Second, what are the determining factors of regulation of the PG synthetic enzymes, and particularly, the cyclooxygenase? Work on mechanisms of regulation of the cyclooxygenase on the other hand has been difficult because this enzyme is subject to rapid inactivation by endoperoxide intermediates in cultured cells (31) .
Several lines of published evidence suggest, however, that PG synthesis regulation is not simply the result of increased phospholipase activity. Thus, Bonser et al. (32) To gain further insight into the mechanism of PDGFdependent PGE2 synthesis stimulation from both endogenous and exogenous AA, we next determined whether other cyclooxygenase products were stimulated by PDGF. The results presented in Fig. 4 demonstrate that PDGF stimulated 6-ketoPGFIa synthesis from both endogenous and exogenous AA and other experiments revealed similar effects of the growth factor on TXB2 and PGF2a synthesis (results not shown). Since the effect of PDGF on stimulation of PG synthesis from exogenous AA included all of the major cyclooxygenasederived products, i.e., PGE2, 6-keto-PGFIa, TXB2, and PGF2a, these results suggest that the effect of PDGF was mediated by activation of the key enzyme of PG and TX synthesis, the cyclooxygenase.
In experiments using protein synthesis inhibition, we showed that the first increase in PGE2 synthesis from both endogenous and exogenous AA was protein synthesis independent while the second increase was completely suppressed in the presence of cycloheximide (Table II) . The protein synthesis insensitivity of the first increase in PGE2 formation might, therefore, reflect rapid activation of the cyclooxygenase pathway by posttranslational modification mechanisms. Although these results are consistent with activation of the cyclooxygenase pathway, the mechanism of activation remains to be elucidated. It is possible that phosphorylation reactions are involved since PDGF has been shown to induce, within minutes, phosphorylation of several proteins (34) .
The second increase of PGE2 synthesis observed between 2 and 4 h after stimulation of the cells was totally dependent on protein synthesis (Table II) . To test whether protein synthesis was required for maintaining high PG synthesis rates from exogenous AA, we determined the kinetics of decline of PGE2 synthesis from exogenous AA in PDGF-stimulated cells (Fig.  5) . The results show that protein synthesis inhibition resulted in rapid inactivation of the cyclooxygenase pathway with approximate half-maximal inhibition between 90 and 120 min. This decline might reflect rapid turnover of enzymes involved in PG synthesis. The results are also consistent with rapid inactivation ofthe cyclooxygenase pathway as has been observed by Brotherton and Hoak (31) in cultured endothelial cells. In both cases, maintenance of high PG synthesis rates required translational activity.
The requirement for protein synthesis appeared to be closely associated with cyclooxygenase activity. Thus, quiescent cells pretreated with aspirin (Fig. 6 ) and stimulated by PDGF thereafter largely recovered during the protein synthesis-sensitive time period, i.e., between 2 and 4 h. No significant recovery was observed during the first 2 h of the cell cycle. Furthermore, PDGF-stimulated cells that were incubated with aspirin, upon removal of aspirin, recovered from cyclooxygenase inhibition within 180 min. In three independent experiments we observed that aspirin-treated cells, after recovery from cyclooxygenase inhibition, synthesized up to 45% more PGE2 from endogenous (not shown) and exogenous AA as compared with the control PDGF-stimulated cultures (Figs. 6 and 7) . Since recovery from aspirin treatment was totally dependent on protein synthesis (results not shown), the enhanced PG synthesis rate after short-term inhibition with aspirin seemed to be due to enhanced de novo synthesis of cyclooxygenase after aspirin treatment. The mechanism underlying this phenomenon is presently unclear. Taken together, the results presented in Figs. [5] [6] [7] show that the PDGF-dependent stimulation of PGE2 occurring between 2 and 4 h is mediated by rapid de novo synthesis of cyclooxygenase.
In conclusion, our results disclose that PDGF has profound direct stimulatory effects on the PG synthesis system in addition to the earlier observed activation of the phospholipase C/ diglyceride lipase pathway (14-16).
Recently, Bailey et al. (35) reported that epidermal growth factor shares some of the activities of PDGF. It will be of major general interest to determine whether activation of cyclooxygenase by agonists represents a general mechanism of PG biosynthesis regulation. If so, our results would have important implications for a variety of physiological as well as pathophysiological conditions. These include the response of tissues to hormones and the regulation of PG, leukotriene, and lipoxin biosynthesis in inflammatory diseases.
